Chris Hutchison, President & CEO – Chris has over 30 years’ experience in the Medical Device industry both in the U.S. and abroad. Most recently, Chris was President and CEO of Cheetah Medical, which was purchased by Baxter in 2019. Prior to joining Cheetah, Chris spent 7 years with Covidien, in a variety of General Management roles in Europe and in the U.S. Before joining Covidien, Chris was President of Smiths Medical’s U.S. subsidiary. Chris began his career at American Hospital Supply Corporation, rising through the sales and marketing ranks there.
Kevin McArdle, Chief Financial Officer – Kevin has extensive experience in clinical stage biotech/regenerative medicine companies and commercial stage medical technology companies. Prior to joining Cheetah Medical he was CFO of Histogenics Corporation where he led the company through its initial public offering in 2014. Prior to joining Histogenics, Mr. McArdle was contract Chief Financial Officer for Avedro, Inc. and INVO Bioscience, Inc., two life science companies. Mr. McArdle also started two seed-stage technologies in the fields of cardiac resynchronization therapy.
Philip Spiegel, Chief Sales Officer – Philip has held a number of senior commercial roles before joining AccuVein. Most recently Philip was at Cheetah Medical where he was Chief Sales Officer before Cheetah was purchased by Baxter in 2019. Prior to Cheetah Medical, Philip was with Smiths Medical for 11 years where he held many senior leadership roles, including VP of Global Sales and Marketing for Business Development and VP Global Integrated Business Planning, Demand Management and Sales Operations.
Scott Pleau, Chief Operations Officer – Scott served as Senior V.P. of Global Operations for Baxter International, overseeing an organization of 35,000 employees in 62 manufacturing locations worldwide. Prior to that, Scott spent 21 years at Covidien in numerous roles of increasing responsibility, finally serving as V.P. of Global Operations managing 23,000 employees in 43 factories worldwide. Scott possesses deep expertise in operational excellence/continuous improvement; developing and implementing successful business strategies and actionable plans and ensuring strategic alignment to company’s mission. Scott is a veteran of the United States Navy.
Jeff Schou, Vice President International Business Development – Jeff is responsible for AccuVein’s business outside the United States. This includes recruitment, development and management of all of our distributors. He has built out a world class network spanning over 130 countries that serves acute care facilities, clinics, blood banks, laboratories, emergency medical services, and home health agencies.
Prior to AccuVein, he ran the Healthcare Industry Solutions Group for Motorola (previously Symbol Technologies) with worldwide responsibilities for all healthcare markets. Jeff has a BS from Dowling College and holds an MS from Polytechnic University.
He has clinical experience as a Critical Care Emergency Medical Technician spanning over twenty years.